NCT04105738 is a clinical trial in Anesthesia, sponsored by J. Matthias Walz.

Who is sponsoring NCT04105738?

NCT04105738 is sponsored by J. Matthias Walz.

What condition does NCT04105738 study?

NCT04105738 studies Anesthesia, Difficult Intubation, Difficult Airway Intubation, Speech Dysfunction, Surgery.

Is NCT04105738 still recruiting?

NCT04105738 is currently terminated. Last updated 15 March 2022.

Are results published for NCT04105738?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2022-03-15 · How we verify

NCT04105738

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Voice Analysis as a Predictor for Difficult Intubations

Terminated Results posted Last updated 15 March 2022

What this trial tests

trial in Anesthesia in 13 participants. Terminated before completion.

Timeline

28 March 2017

Primary endpoint
19 February 2021

22 February 2021

Quick facts

Lead sponsor	J. Matthias Walz
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	13
Start date	28 March 2017
Primary completion	19 February 2021
Estimated completion	22 February 2021
Sites	1 location across United States

Conditions studied

Anesthesia — all drugs for Anesthesia →
Difficult Intubation — all drugs for Difficult Intubation →
Difficult Airway Intubation — all drugs for Difficult Airway Intubation →
Speech Dysfunction — all drugs for Speech Dysfunction →

Sponsor

J. Matthias Walz

Who can join

18 and older, any sex, with Anesthesia or Difficult Intubation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate if signal processing can detect subtle changes in speech production clinically relevant to oropharynx anatomy that may provide an objective measure in the assessment of the presumed difficulty of intubation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Anesthesia

Currently open trials in the same condition.

NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
NCT07465185 — Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery · Phase 2 · recruiting
NCT07269808 — Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration · Phase 3 · recruiting
NCT07443254 — Prospective IR-led Sedation Feasibility · Phase 1, PHASE2 · recruiting

Other J. Matthias Walz trials

Trials by the same sponsor.

NCT03630003 — Manually Operated Communication System · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04105738 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by J. Matthias Walz
Last refreshed: 15 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04105738.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing